Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Polychemotherapy in inoperable bronchial carcinoma].

C G Schmidt

    Strahlentherapie
    |February 1, 1984
    PubMed
    Summary

    Histologic tumor type significantly impacts bronchial carcinoma prognosis and treatment. Differentiating small-cell from non-small-cell lung cancer is crucial for effective chemotherapy and improved survival rates.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anti-depressants and anti-convulsants for the treatment of neuropathic pain syndromes in cancer patients.

    Onkologie·1991
    Same author

    Etoposide in patients with previously untreated non-small-cell lung cancer: a phase I study.

    Cancer chemotherapy and pharmacology·1991
    Same author

    Etoposide, ifosfamide, and methotrexate with or without bleomycin in refractory or recurrent lymphomas.

    Annals of oncology : official journal of the European Society for Medical Oncology·1991
    Same author

    Ifosfamide, methotrexate and 5-fluorouracil for pretreated advanced breast cancer.

    Oncology·1991
    Same author

    Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: initial response and long-term results in 54 patients.

    European journal of cancer (Oxford, England : 1990)·1991
    Same author

    [Burkitt's lymphoma in HIV-infected patients].

    Deutsche medizinische Wochenschrift (1946)·1990

    Area of Science:

    • Oncology
    • Pulmonology
    • Cancer Biology

    Context:

    • Bronchial carcinoma, or lung cancer, exhibits diverse behaviors based on histologic subtype.
    • Accurate tumor classification is essential for determining appropriate therapeutic strategies and predicting patient outcomes.

    Purpose:

    • To highlight the critical role of histologic tumor type in bronchial carcinoma management.
    • To differentiate the clinical behavior and therapeutic responses of small-cell lung cancer versus non-small-cell lung cancer.

    Summary:

    • Small-cell lung cancer (SCLC) demonstrates rapid growth and early dissemination, making it highly responsive to antiproliferative chemotherapy, often achieving complete remission and prolonged survival in limited disease cases.
    • Non-small-cell lung cancer (NSCLC) generally shows a lower response rate to chemotherapy, with adenocarcinomas being relatively refractory and squamous cell carcinomas responding slightly better.
    • While chemotherapy improves prognosis for inoperable SCLC, recurrences remain a challenge, necessitating further research into radiotherapy and precise disease staging.

    Impact:

    • Establishes histologic differentiation as a cornerstone of lung cancer treatment planning.
    • Underscores the differential chemosensitivity between SCLC and NSCLC subtypes.
    • Identifies the need for further clinical trials to optimize multimodal treatment approaches for lung cancer, particularly concerning radiotherapy's role.

    Related Experiment Videos